Feature Story  

Jazz Pharma's sleep disorder drug gets European panel backing

Fri, Nov 15, 2019
Jazz Pharmaceuticals Plc's treatment for a form of sleep disorder has been recommended for approval in Europe by a panel of the European Medicines Agency (EMA), the regulator said on Friday.
  Newsifi

New York, New York

Email : info@newsifi.com